Breast and Cervical Cancer

Breast cancer is the commonest female malignancy accounting for about 22% of all new female cancers. It is expected to affect 1:8 (12%) of women during their lifetime. The incidence in the Gulf and Arab world is approaching that in the West. Many women are anxious about their family history of breast cancer and what if anything they can do about it. In this presentation we will discuss breast cancer susceptibility and how to reduce the risk in general, the relevance of the individual’s family history, the objective assessment and risk stratification of family history and whether the Oral Contraceptive Pill (OCP) and Hormone Replacement Therapy (HRT) could increase the risk? Finally, what are the modern options available for a woman with a significant family history of breast cancer? It includes a review of the latest NICE UK guidelines on breast screening, chemoprevention and risk-reducing bilateral skin sparing mastectomy with immediate reconstruction.